The Management of Paget's Disease of Bone
- 20 February 1997
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (8) , 558-566
- https://doi.org/10.1056/nejm199702203360807
Abstract
Paget's disease of bone is a localized, monostotic or polyostotic disease characterized by increased bone remodeling, bone hypertrophy, and abnormal bone structure that leads in symptomatic patients to pain and bone deformity. Complications involve the bones (fractures and neoplastic degeneration), joints (osteoarthritis), and nervous system. The short-term objective of treatment is to alleviate bone pain, and the long-term objective is to minimize or prevent the progression of the disease.Pathology, Epidemiology, and EtiologyPagetic bone is characterized by major disorganization in both the architecture and the lamellar texture of bone. These abnormalities are the results of major disturbances in bone . . .Keywords
This publication has 56 references indexed in Scilit:
- Treatment of paget's disease of bone with the new bisphosphonate ibandronate (BM 21.0955) by intravenous injection and continuous infusionBone, 1995
- Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's diseaseJournal of Bone and Mineral Research, 1995
- Long-term effects of intravenous pamidronate in fibrous dysplasia of boneThe Lancet, 1994
- Intravenous aminopropylidene bisphosphonate (APD) in the treatment of paget's bone diseaseJournal of Bone and Mineral Research, 1987
- Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.Annals of the Rheumatic Diseases, 1986
- Treatment of Paget's Disease of Bone with Ethane-1, Hydroxy-1,1 Diphosphonate (EHDP) at a Low Dosage (5 mg/kg/day)Published by Wolters Kluwer Health ,1983
- Review of Fracture Experience During Treatment of Paget??s Disease of Bone with Etidronate Disodium (EHDP)Published by Wolters Kluwer Health ,1983
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Mithramycin treatment of pacet's disease of bone exploration of combined mithramycin-ehdp therapyArthritis & Rheumatism, 1980
- Biochemical measurements in Paget's disease of boneEuropean Journal of Clinical Investigation, 1977